Insider Trades of BARRETT M JAMES Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date ▲ Type Tran OwnerType Shares Traded Last Price Shares Held
TABLEAU SOFTWARE INC Beneficial Owner (10%) 03/05/2014 Form 4 Sell indirect 17,424 95.5
TABLEAU SOFTWARE INC Beneficial Owner (10%) 03/05/2014 Form 4 Sell indirect 35,000 94.2813
TABLEAU SOFTWARE INC Beneficial Owner (10%) 03/06/2014 Form 4 Sell indirect 50,000 94.3168 58,624
TABLEAU SOFTWARE INC Beneficial Owner (10%) 03/07/2014 Form 4 Sell indirect 23,624 90.6187 35,000
AEROHIVE NETWORKS, INC Beneficial Owner (10%) 04/02/2014 Form 4 Acquisition (Non Open Market) indirect 4,653,589 0 4,673,589
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 06/05/2014 Form 4 Disposition (Non Open Market) indirect 505,000 0
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 06/05/2014 Form 4 Acquisition (Non Open Market) direct 148 0 148
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 06/05/2014 Form 4 Acquisition (Non Open Market) indirect 6,282 0 2,385,503
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 06/06/2014 Form 4 Sell direct 148 26.7703
HYPERION THERAPEUTICS INC Beneficial Owner (10%) 06/06/2014 Form 4 Sell indirect 1,282 26.7968 2,384,221
ROKA BIOSCIENCE, INC. Director 07/22/2014 Form 4 Acquisition (Non Open Market) indirect 2,828,743 0 2,833,477
ROKA BIOSCIENCE, INC. Director 07/22/2014 Form 4 Buy indirect 383,333 12 3,216,810
LOXO ONCOLOGY, INC. Director 08/06/2014 Form 4 Acquisition (Non Open Market) indirect 1,558,651 0 1,558,651
LOXO ONCOLOGY, INC. Director 08/06/2014 Form 4 Buy indirect 230,769 13 1,789,420
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/08/2014 Form 4 Sell indirect 675,000 6.6201 4,961,573
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/12/2014 Form 4 Sell indirect 35,540 6.7583 9,887,606
EPIZYME, INC. Beneficial Owner (10%) 08/14/2014 Form 4 Disposition (Non Open Market) indirect 1,302,900 0
EPIZYME, INC. Beneficial Owner (10%) 08/14/2014 Form 4 Acquisition (Non Open Market) direct 325 0 325
EPIZYME, INC. Beneficial Owner (10%) 08/14/2014 Form 4 Acquisition (Non Open Market) indirect 16,636 0 12,900
CVENT INC Beneficial Owner (10%) 08/14/2014 Form 4 Disposition (Non Open Market) indirect 1,010,000 0

Create your free portfolio